DrugSK:一个堆叠的集体学习框架,用于预测多种疾病的药物组合
Siqi Chen1, Nan Gao2, Chunzhi Li1
1College of Medical Devices, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.
Journal of chemical information and modeling
|June 20, 2024
概括
一个新的机器学习模型DrugSK准确地预测了药物组合协同作用. 这种方法有助于发现有效的新药组合,比如Drafloxacin与抗真菌药,以改善治疗结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 机器学习 机器学习
背景情况:
- 组合疗法旨在提高疗效和减少副作用.
- 机器学习显示了预测药物协同作用的潜力,但现有的模型面临着新药和广泛应用的局限性.
- 预测协同药物组合对于推进治疗策略至关重要.
研究的目的:
- 开发一个全面的机器学习模型 (DrugSK),用于预测各种药物类别的药物相互作用和协同作用.
- 通过处理多种类型的药物并使新药的预测成为可能,克服现有模型的局限性.
- 在临床环境中验证模型的预测准确性和实用性.
主要方法:
- 使用SMILES-BERT从3492种药物中提取结构信息.
- 在48,756种药物组合反应上训练了一种综合学习模型.
- 使用随机森林,支持矢量机器,XGBoost和物流回归的双层学习方法.
主要成果:
- 药物SK模型证明了药物组合协同效应的准确预测.
- 在抗菌Drafloxacin和抗真菌Isavuconazonium之间对Candida albicans进行了验证的协同作用.
- 确定了德拉夫洛克萨和其他抗真菌剂之间的协同作用趋势.
结论:
- 药物SK提供了药物组合协同效应的准确和概率预测,适用于各种药物类别.
- 该模型的发现为临床治疗提供了洞察力,特别是对于皮肤感染.
- 药物SK在预测药物协同作用方面取得了重大进展,为新型组合疗法铺平了道路.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
68
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
68
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252


